Echo Therapeutics
Echo Therapeutics is a transdermal medical device company with deep expertise in advanced skin permeation technology. Echo is developing its Prelude® SkinPrep System as a platform technology to allow for significantly enhanced and painless skin permeation that will enable two important applications:
Needle-free drug delivery, with the delivery of lidocaine as the first application. Additional applications for painless, needle-free delivery of drugs are planned.
Analyte extraction, with the Symphony® tCGM System for needle-free, continuous glucose monitoring in hospital patients as the first application.
Echo believes that transdermal drug delivery and analyte monitoring is a much better way of patient care than the current paradigm of invasive, needle-based therapy. Prelude has the potential to provide a safe, painless, easy-to-use and cost effective skin permeation process that Echo believes will increase patient comfort, compliance and ultimately patient outcomes.
